Go Ad-Free
logoThe People's Perspective on Medicine

How Much Does It Really Cost to Develop a New Drug?

A new analysis show that the cost to develop a new cancer drug is high, but not as high as the industry has claimed. Moreover, the cost is recouped quickly.

New cancer drugs have become extremely expensive. It is not unusual for immunotherapy treatments to cost between $100,000 and $200,000 per year. Often, the pharmaceutical industry justifies such a price tag because of the high cost to develop these medications.

What Does It Cost to Develop a New Cancer Drug?

One frequently cited analysis lists the cost to develop a new drug and bring it to market at $2.7 billion. Now a new analysis published in JAMA Internal Medicine challenges that estimate.

The researchers calculated the total R&D spending from the first year of a cancer drug’s development through FDA approval. Instead of nearly $3 billion per drug, the authors suggested that the median cost would be closer to $648 million.

That median cost rises to $757 million if you take into account an opportunity cost of 7 percent. (That means, the cost of having your money tied up in research instead of investing it in the stock market.) The analysts used data from ten companies’ filings with the Securities and Exchange Commission.

They conclude that:

“In a short period, development cost is more than recouped, and some companies boast more than a 10-fold higher revenue than R&D spending–a sum not seen in other sectors of the economy.”

Prasad & Mailankody, JAMA Internal Medicine, online, Sept. 11, 2017

High Cost of Prescription Drugs:

This is not the first time that academic analysts have noted that prices may be outstripping purported R&D expenses. In 2015, researchers pointed to a 400 percent hike in the consumer prices of dermatological drugs between 2009 and 2015. And Martin Shkreli, former head of Turing Pharmaceuticals, made headlines when he boosted the price of an old drug for toxoplasmosis by more than 5,000 percent.

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.8- 14 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies..
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.